Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P142. Functional symptoms in inflammatory bowel disease
P142. Sharp decrease in calprotectin as a biomarker for remission in UC patients under infliximab therapy
P142. Subcutaneously administered golimumab induction therapy improves health states measured by EQ-5D in patients with moderately to severely active ulcerative colitis: results from PURSUIT-SC
Authors:

P. Gibson1, B. Feagan2, C. Marano3, R. Strauss3, C. Han4, J. Johanns3, H. Zhang3, C. Guzzo3, J.-F. Colombel5, W. Reinisch6, J. Collins7, G. Jarnerot8, P. Rutgeerts9, W. Sandborn10, 1Alfred Hospital, Melbourne, Australia, 2Robarts Research Institute, Canada, 3Janssen Research & Development, LLC, United States, 4Janssen Global Services LLC, United States, 5Hôpital Claude Huriez, France, 6Universitätsklinik für Innere Medizin IV, Austria, 7Oregon Health Sciences University, United States, 8Orebro University Hospital, Sweden, 9University Hospital, Gasthuisberg, Belgium, 10University of California San Diego, United States

P142

Quantification of inflammation in small bowel Crohn's disease (SBCD) patients by videocapsule endoscopy (VCE) and magnetic resonance enterography (MRE)

Authors:

U. Kopylov*1, E. Klang2, S. Ben-Horin3, D. Yablecovitch3, A. Lahat3, S. Neuman3, N. Rozendorn2, N. Levhar3, M.M. Amitai2, R. Eliakim3

1Sheba Medical Center, Gastroenterology, Tel Hashomer, Israel, 2Sheba Medical Center, Department of Diagnostic Imaging, Tel Hashomer, Israel, 3Chaim Sheba Medical Center, Gastroenterology, Ramat Gan, Israel

P143.

Screening for latent tuberculosis in patients with inflammatory bowel diseases: impact of immunosuppressive drugs in the performance of an interferon-gamma release assay

Authors:

J. Machado, P. Sousa, P. Ministro, A. Silva, Centro Hospitalar Tondela-Viseu, Gastroenterology, Viseu, Portugal

P143. Incidental diagnosis of inflammatory bowel disease in a British bowel cancer screening cohort
P143. Soluble syndecan-1 (CD138) – a novel biomarker in patients with inflammatory bowel disease
Authors:

D. Yablecovitch1, A. Stein1,2, T. Naftali1,2, G. Gabay1, I. Laish1, F. Konikoff1,2, 1Meir Medical Center, Gastroenterology, Kfar Saba, Israel, 2Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel

P143. Transplantation of allogeneic mesenchymal stromal cells of bone marrow reduces the level of antibodies to infliximab in patients with Crohn's disease
P143

The Usefulness of Ultra-low Dose CT colonography for Assessing Mucosal Inflammation in Patients with Ulcerative Colitis

Authors:

M. Miyamura*1, K. Takeuchi1, T. Arai1, R. Kasai2, A. Yamada1, Y. Suzuki1

1Toho University, Sakura Medical Centre, Division of Gastroenterology, Department of Internal Medicine, Sakura, Japan, 2Toho University, Sakura Medical Centre, Radiology, Sakura city, Japan

P144.

Sarcopenia and osteopenia in patients with Crohn's disease

Authors:

I.A. Pintilie, I. Cracana, O. Jigaranu, C. Mihai, C. Cijevschi, University of Medicine and Pharmacy “Gr. T. Popa” Iasi, Institute of Gastroenterology, Iasi, Romania

P144. Laboratory predictors of the effectiveness of transplantation of allogeneic mesenchymal stromal cells of bone marrow in patients with ulcerative colitis
P144. Serum neutrophil gelatinase B-associated lipocalin–matrix metalloproteinase-9 (NGAL-MMP-9) complex as a surrogate marker for mucosal healing in ulcerative colitis
Authors:

M. de Bruyn1, I. Arijs2, W.-J. Wollants2, K. Machiels2, K. Van Steen3, M. Ferrante2, P. Rutgeerts2, S. Vermeire2, G. Opdenakker1, 1KULeuven, Rega Institute, Immunobiology, Leuven, Belgium, 2KU Leuven, Clinical and Experimental Medicine, TARGID, Leuven, Belgium, 3University of Liège, Montefiore Institute, Systems and Modeling Unit, Liège, Belgium

P144. Urinary NGAL: A reliable marker of minor tubular injury in inflammatory bowel disease
P144

Characterisation of incident cases of cancer in Inflammatory Bowel Disease: A prospective multicenter nested case-control IG-IBD study

Authors:

L. Biancone*1, M.L. Scribano2, A. Armuzzi3, R. D'Incà4, C. Papi5, L. Spina6, A. Ruffa1, C. Petruzziello1, L. Guidi3, A. Kohn2, E. Calabrese1, F. Mocciaro7, P. Alvisi8, E. Angelucci1, R. Monterubbiansei2, W. Fries9, G. Riegler10, F. Castiglione11, I. Frankovic4, G. Margagnoni5, S. Renna12, R. Di Mitri7, G. Meucci13, F. Rogai14, S. Ardizzone15, A. Rossi1, A. Orlando12, F. Pallone1

1Università di Roma Tor Vergata, Medicina dei sistemi, cattedra di Gastroenterologia, Roma, Italy, 2AO S. Camillo Forlanini ~ Roma ~ Italy, GI Unit, Rome, Italy, 3Università Cattolica, CIC, Roma, Italy, 4University of Padova, Gastroenterology Department, Padova, Italy, 5AO S. Filippo Neri, UOC GE/Hep, Roma, Italy, 6Università S. Donato, Gastroenterologia, Milano, Italy, 7ARNAS Civico-Di Cristina-Benfratelli Hospital, Gastroenterology and Endoscopy Unit, Palermo, Italy, 8Ospedale Maggiore, Department of Pediatric, Bologna, Italy, 9Università di Messina ~ , GI Unit, Messina, Italy, 10Seconda Università Napoli, SUN, Napoli, Italy, 11Università Federico II , GI Unit, Rome, Italy, 12Ospedale Cervello, Medicina Interna, Palermo, Italy, 13S. Giuseppe Hospital, Gastroenterology, Milano, Italy, 14AOU Careggi, Largo Brambilla,, Department of Gastroenterology, Firenze, Italy, 15Fatebenefratelli Hospital, Fatebenefratelli Hospital, Milano, Italy

P145.

Small bowel capsule endoscopy for assessing the early postoperative recurrence of Crohn's disease: Correlation with the endoscopic score at 6 and 12 months in a prospective study

Authors:

G. Condino1, E. Calabrese1, S. Onali1, E. Lolli1, M. Ascolani1, F. Zorzi1, G. Sica2, C. Petruzziello1, F. Pallone1, L. Biancone1, 1Università di Roma Tor Vergata, Medicina dei sistemi, cattedra di Gastroenterologia, Roma, Italy, 2Università di Roma Tor Vergata, Chirurgia, Roma, Italy

P145. Clinical and phenotypic characteristics of Crohn's disease in elderly people: A population-based study
P145. Is elevated CRP a predictor of efficacy in ulcerative colitis? Post-hoc analysis from a placebo-controlled study with interferon-β-1a
P145. Risk factors for repetitive ileocolic resection in Crohn's disease patients
Authors:

C.N. Manser1, P. Frei2, L. Biedermann1, J. Mwinyi3, S. Vavricka4, G. Rogler1, 1University Hospital of Zurich, Clinic of Gastroenterology and Hepatology, Zurich, Switzerland, 2See Spital Horgen, Gastroenterology Unit, Clinic of Internal Medicine, Horgen, Switzerland, 3University Hospital Zurich, Department of Clinical Pharmacology and Toxicology, Zurich, Switzerland, 4Triemlispital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland

P145

Fecal calprotectin correlates with inflammatory disease activity as seen on CT imaging of the small bowel better than clinical assessment

Authors:

G. Rosenfeld*1, J. Brown2, P. Vos2, J. Leipsic2, R. Enns3, B. Bressler3

1University of British Columbia, Medicine, Vancouver, Canada, 2University of British Columbia, Radiology, Vancouver, Canada, 3University of British Columbia, Division of Gastroenterology, Vancouver, Canada

P146.

Role of fecal neutrophil gelatinase-associated lipocalin assessment in patients with inflammatory bowel disease

Authors:

D. Mukhametova1, D. Abdulganieva1, O. Zinkevich2, N. Saphina2, A. Odintsova3, M. Koporulina2, 1Kazan State Medical University, Hospital Therapy, Kazan, Russian Federation, 2Kazan State Medical Academy, Central Research Laboratory, Kazan, Russian Federation, 3Republican Clinical Hospital, Department of Gastroenterology, Kazan, Russian Federation